Zhou Xing
About
Zhou Xing is a scholar working on Immunology, Infectious Diseases and Epidemiology.
According to data from OpenAlex, Zhou Xing has authored 196 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Immunology, 80 papers in Infectious Diseases and 51 papers in Epidemiology. Recurrent topics in Zhou Xing's work include Tuberculosis Research and Epidemiology (58 papers), Immunotherapy and Immune Responses (39 papers) and Immune Response and Inflammation (38 papers). Zhou Xing is often cited by papers focused on Tuberculosis Research and Epidemiology (58 papers), Immunotherapy and Immune Responses (39 papers) and Immune Response and Inflammation (38 papers). Zhou Xing collaborates with scholars based in Canada, United States and United Kingdom. Zhou Xing's co-authors include Jack Gauldie, Manel Jordana, Mangalakumari Jeyanathan, Anna Zganiacz, Sam Afkhami, Michael Santosuosso, Sarah McCormick, Gerard Cox, Heinz Baumann and Brian D. Lichty and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
In The Last Decade
Zhou Xing
193 papers receiving 11.4k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Zhou Xing Canada | 58 | 6.1k | 3.7k | 2.6k | 2.2k | 1.7k | 196 | 11.7k | ||
| Warwick J. Britton Australia | 62 | 5.0k 0.8× | 6.8k 1.8× | 5.5k 2.1× | 2.8k 1.3× | 1.4k 0.8× | 315 | 14.2k | ||
| Matthew J. Fenton United States | 63 | 8.6k 1.4× | 2.0k 0.5× | 3.0k 1.1× | 3.5k 1.6× | 946 0.6× | 188 | 14.9k | ||
| Tracy Hussell United Kingdom | 53 | 5.1k 0.8× | 1.9k 0.5× | 3.2k 1.2× | 2.2k 1.0× | 2.4k 1.4× | 145 | 11.5k | ||
| Peter Garred Denmark | 71 | 11.2k 1.8× | 2.0k 0.5× | 2.5k 0.9× | 2.5k 1.1× | 1.5k 0.9× | 416 | 17.2k | ||
| Seppo Meri Finland | 75 | 9.0k 1.5× | 2.0k 0.5× | 2.6k 1.0× | 3.0k 1.4× | 647 0.4× | 389 | 17.4k | ||
| Hardy Kornfeld United States | 60 | 5.4k 0.9× | 4.7k 1.3× | 4.2k 1.6× | 2.8k 1.3× | 663 0.4× | 179 | 12.5k | ||
| Kelly D. Smith United States | 42 | 7.7k 1.3× | 1.4k 0.4× | 2.1k 0.8× | 3.4k 1.6× | 1.1k 0.7× | 121 | 13.8k | ||
| David B. Lewis United States | 52 | 4.6k 0.8× | 1.4k 0.4× | 1.7k 0.6× | 1.9k 0.9× | 738 0.4× | 123 | 9.3k | ||
| Sarah L. Gaffen United States | 70 | 10.9k 1.8× | 3.7k 1.0× | 3.5k 1.3× | 3.3k 1.5× | 852 0.5× | 150 | 18.4k | ||
| Benjamin J. Marsland Switzerland | 53 | 3.6k 0.6× | 1.9k 0.5× | 1.6k 0.6× | 5.3k 2.5× | 1.7k 1.0× | 122 | 11.8k |
Countries citing papers authored by Zhou Xing
Since
Specialization
Citations
This map shows the geographic impact of Zhou Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhou Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhou Xing more than expected).
Fields of papers citing papers by Zhou Xing
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Zhou Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhou Xing. The network helps show where Zhou Xing may publish in the future.
Co-authorship network of co-authors of Zhou Xing
This figure shows the co-authorship network connecting the top 25 collaborators of Zhou Xing. A scholar is included among the top collaborators of Zhou Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhou Xing. Zhou Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kang, Alisha, Sam Afkhami, Kanwaldeep Singh, et al.. (2024). LPS-induced lung tissue-resident trained innate immunity provides differential protection against pneumococci and SARS-CoV-2. Cell Reports. 43(10). 114849–114849.
2.
Zhou, Zhaokai, Jiaxin Xu, Shutong Liu, et al.. (2024). Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy. Biomarker Research. 12(1). 97–97.
3.
Schertel, Andreas, et al.. (2023). Internal microstructure of spray dried particles affects viral vector activity in dry vaccines. International Journal of Pharmaceutics. 640. 122988–122988.
4.
Kang, Alisha, Ramandeep Singh, Sam Afkhami, et al.. (2023). Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung. EMBO Molecular Medicine. 15(7). e17084–e17084.
5.
Huang, Lei, et al.. (2023). The characteristics and mechanism in combustion extinguished process based on self-extinguished solid propellants. Journal of Physics Conference Series. 2478(3). 32068–32068.
6.
Saint‐Criq, Vinciane, Bérengère Villeret, Aurélie Hatton, et al.. (2017). Pseudomonas aeruginosaLasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway. Thorax. 73(1). 49–61.
7.
Coulombe, François, Joanna Jaworska, Mark Verway, et al.. (2014). Targeted Prostaglandin E2 Inhibition Enhances Antiviral Immunity through Induction of Type I Interferon and Apoptosis in Macrophages. Immunity. 40(4). 554–568.
8.
McCormick, Sarah, Christopher R. Shaler, & Zhou Xing. (2011). Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy. Expert Review of Respiratory Medicine. 5(1). 75–85.
9.
Jeyanathan, Mangalakumari, Sarah McCormick, Daniela Damjanovic, et al.. (2009). Murine Airway Luminal Antituberculosis Memory CD8 T Cells by Mucosal Immunization Are Maintained Via Antigen-Driven In Situ Proliferation, Independent of Peripheral T Cell Recruitment. American Journal of Respiratory and Critical Care Medicine. 181(8). 862–872.
10.
Santosuosso, Michael, Sarah McCormick, & Zhou Xing. (2005). Adenoviral Vectors for Mucosal Vaccination Against Infectious Diseases. Viral Immunology. 18(2). 283–291.
11.
Santosuosso, Michael, Xizhong Zhang, Sarah McCormick, et al.. (2005). Mechanisms of Mucosal and Parenteral Tuberculosis Vaccinations: Adenoviral-Based Mucosal Immunization Preferentially Elicits Sustained Accumulation of Immune Protective CD4 and CD8 T Cells within the Airway Lumen. The Journal of Immunology. 174(12). 7986–7994.
12.
Zganiacz, Anna, Michael Santosuosso, Jun Wang, et al.. (2004). TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. Journal of Clinical Investigation. 113(3). 401–413.
13.
Wang, Jun, Lisa Thorson, Richard W. Stokes, et al.. (2004). Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis. The Journal of Immunology. 173(10). 6357–6365.
14.
Huaux, François, et al.. (2003). Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis. The Journal of Immunology. 171(10). 5470–5481.
15.
Emtage, Peter, Zhou Xing, Yonghong Wan, et al.. (2002). Adenoviral-Mediated Gene Transfer of Lymphotactin to the Lungs of Mice and Rats Results in Infiltration and Direct Accumulation of CD4 + , CD8 + , and NK Cells. Journal of Interferon & Cytokine Research. 22(5). 573–582.
16.
Lu, Hang, Zhou Xing, & Robert C. Brunham. (2002). GM-CSF Transgene-Based Adjuvant Allows the Establishment of Protective Mucosal Immunity Following Vaccination with Inactivated Chlamydia trachomatis. The Journal of Immunology. 169(11). 6324–6331.
17.
Miller, George, et al.. (2002). Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Overexpression In Vivo Results in the Long-Term Recruitment of a Distinct Dendritic Cell Population with Enhanced Immunostimulatory Function. The Journal of Immunology. 169(6). 2875–2885.
18.
Kolb, Martin, Peter J. Margetts, Patricia J. Sime, et al.. (2001). Transient Transgene Expression of Decorin in the Lung Reduces the Fibrotic Response to Bleomycin. American Journal of Respiratory and Critical Care Medicine. 163(3). 770–777.
19.
Xing, Zhou, et al.. (2001). Enhanced Protection Against Fatal Mycobacterial Infection in SCID Beige Mice by Reshaping Innate Immunity with IFN-γ Transgene. The Journal of Immunology. 167(1). 375–383.
20.
Xing, Zhou, et al.. (2000). IL-12-Independent Th1 - Type Immune Responses to Respiratory Viral Infection: Requirement of IL-18 for IFN-γ Release in the Lung But Not for the Differentiation of Viral-Reactive Th1 - Type Lymphocytes. The Journal of Immunology. 164(5). 2575–2584.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Warwick J. Britton Breakdown of academic impact, for papers by Matthew J. Fenton Breakdown of academic impact, for papers by Tracy Hussell Breakdown of academic impact, for papers by Peter Garred Breakdown of academic impact, for papers by Seppo Meri Breakdown of academic impact, for papers by Hardy Kornfeld Breakdown of academic impact, for papers by Kelly D. Smith Breakdown of academic impact, for papers by David B. Lewis Breakdown of academic impact, for papers by Sarah L. Gaffen Breakdown of academic impact, for papers by Benjamin J. Marsland